Work

32-week data from a multiple ascending-dose study with verekitug, a novel antibody to the human TSLP receptor (TSLPR), in adults with asthma

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.oa3651

Authors: Aaron Deykin, Chaim M. Brinkman, Peter Lloyd, Ivan Nestorov, Ashish Kalra, Subhabrata Biswas, Arkadeep Sinha, Sumathi Sivapalasingam, Oren Becker, Dave Singh

Institution: University of Manchester

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404104763

Cites:

Cited by: 2

Related to: 10